A 33-year-old Omani woman presented with severe lower abdominal pain for 3 days after undergoing ICSI (intra-cytoplasmic sperm injection) treatment for primary infertility. She has a history of infertility for 6 years, including a failed IUI (intrauterine insemination) treatment 2 years ago. A physical exam and medical history were taken. The woman has been experiencing primary infertility for 6 years despite various fertility treatments.
Uterine fibroid - Case scenarios and DiscussionHaynes Raja
This presentation is prepared to meet out the undergraduate medical student needs especially to understand the practical aspects of uterine fibroid and to rapidly revise some important viva questions.
Dedicated to my Great Teachers in the Dept. of Obstetrics & Gynaecology Dr. Lavanya Kumari and Dr. Sangeereni, Inspiring Friends Dr. Paulin Benedict, Dr. Jeyakumar Meyyappan and Dr. Hannah Jane and our REVELLIONZ 08’ batch.
Presentation on the description of normal and abnormal uterine bleeding, menstrual cycle, FIGO classification with PALM-COEIN, common differentials of AUB, assessment, diagnosis, and management.
An Obstetrics and gynecology presentation: A 20 years old single female undergraduate presents to the emergency unit with fever, lower abdominal pain and abnormal vaginal discharge of 5 days duration. Discuss her management
India is the highest TB burden country accounting for more than one-fourth of the global incidence .Genital TB is found in 5-10% of women with infertility problems, with low rates in Australia (1%) and high rates of up to 19% in India (ICMR,2011)
Uterine fibroid - Case scenarios and DiscussionHaynes Raja
This presentation is prepared to meet out the undergraduate medical student needs especially to understand the practical aspects of uterine fibroid and to rapidly revise some important viva questions.
Dedicated to my Great Teachers in the Dept. of Obstetrics & Gynaecology Dr. Lavanya Kumari and Dr. Sangeereni, Inspiring Friends Dr. Paulin Benedict, Dr. Jeyakumar Meyyappan and Dr. Hannah Jane and our REVELLIONZ 08’ batch.
Presentation on the description of normal and abnormal uterine bleeding, menstrual cycle, FIGO classification with PALM-COEIN, common differentials of AUB, assessment, diagnosis, and management.
An Obstetrics and gynecology presentation: A 20 years old single female undergraduate presents to the emergency unit with fever, lower abdominal pain and abnormal vaginal discharge of 5 days duration. Discuss her management
India is the highest TB burden country accounting for more than one-fourth of the global incidence .Genital TB is found in 5-10% of women with infertility problems, with low rates in Australia (1%) and high rates of up to 19% in India (ICMR,2011)
Presentation covers 3 topics: 1) Definition of infertility with brief review of female reproduction. 2) Discussion of how fertility status is evaluated with a description of some of the tests that are performed. 3) Review of several treatment options. By Dr. Arlene Morales of Fertility Specialists Medical Center (FSMG) http://ivfspecialists.com/
Infertility has become a major problem among many people. Infertility clinics are now becoming an important industry. Here are some of the infertility treatments offered:
This presentation provide most of the basic principles of maintain sterilly in a sterile invasive procedure in an operating theatre. All operating theatre staff will find useful/relevant.
Introduction
Natural conception
Epidemiologic figures
Factors affect the natural conception rate
Causes of subfertility
Female causes of subfertility
ovulation
Ovarian problems
Marker of ovarian reserve
Tubal blockage
Endometrial factors
Uterine factors
Cervical factors
History and PE
Investigations
Treatment
Male subfertility
Hypothalamic-pituitary disease
Obesity
Primary hypogonadism
Sperm transport disorders
Defective ejaculation
History and PE
Investigations
Surgical sperm retrieval
Cryopreservation of gametes
As an intern doctor in Gyne department , this presentation outlines the steps of assessment of an infertile couple including history taking , examinations and relevant investigations and imagings .
ART refers to methods used to achieve pregnancy by artificial or partially artificial means.
• INCLUDES- artificial insemination, In vitro fertilization (IVF) , Zygote intrafallopian transfer (ZIFT) or Tubal Embryo Transfer, Gamete intrafallopian transfer (GIFT) , Intracytoplasmic sperm injection (ICSI)
Female and male infertility Causes & Management by Asar KhanAsar Khan
In this Presentation we have included the male and female infertility their causes and Management. we hope that it will provide you some basic information regarding this issues.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
2. Case:Case:
A 33 years old Omani lady k/o primary infertility was present to the A&E with referral
from private clinic .
She presented with sever lower abdominal pain from 3 days which get worse
with time. It was colicky in nature, not radiating, and she can’t tolerated
with it. There was history of abdominal distention, SOB, vomiting and
diarrhea.
4 days before pt. underwent Intra cytoplasmic sperm injection (ICSI)
12-19/1/2013 : fertility medication used for inducing final oocyte maturation
Married for 6 years
2 years back, Intrauterine insemination (IUI) had been done in Muscat
private hospital but failed.
She doesn’t have any thyroid problems, no abnormal weight gain or weight
loss, no excessive hair growth.
3. Menstrual History:Menstrual History:
Her menarche age is 15 years. Menstrual periods were
irregular. The character of the flow is normal without
clots. No inter menstrual bleeding .Her LMP was on
10/1/2013.
Contraceptive History:
She didn’t use any kind of contraception methods.
Past obstetric history
primary infertility
4. Marital historyMarital history
She is the first wife of her husband. She is married once. They sleep
together normally with adequate frequency. She does not have any
bleeding or dysuria with sexual intercourse.
Her husband is a 34 years old Omani man works as a office worker
in the educational ministry. His health condition is good. He has no
problems during intercourse and his work does not affect his
relationships with his wife.
Previous medical & surgical History
Systemic review:(unremarkable)
5. Family history:
Related to her husband
Her father and mother are consanguinity.
Her father has DM & HTN.
Her sisters and brother had thyroid problems & under medication.
Social history:
She is a teacher, living with her husband . She is not
smoking or alcohol consumer.
Unexplained primary infertility presenting with
ovarian hyperstimulation syndrom
7. Requirements for ConceptionRequirements for Conception
Production of healthy egg and spermegg and sperm
Unblocked tubesUnblocked tubes that allow sperm to reach the egg
The sperms ability to penetrateability to penetrate and fertilize the egg
ImplantationImplantation of the embryo into the uterus
Finally a healthy pregnancy
8. InfertilityInfertility
The inability to conceive following unprotected sexual
intercourse
1 year (age < 35) or 6 months (age >35)
Affects 15% of reproductive couples
Men and women equally affected
9. InfertilityInfertility
Reproductive age for women:Reproductive age for women:
Generally 15-44 years15-44 years of age
20% of women have their first child after age 30
1/3 of couples1/3 of couples over 35 years have fertility problems:
Ovulation decreases
Health of the egg declines
Health problems develop
With the proper treatment 85% of infertile couples can85% of infertile couples can
expect to have a childexpect to have a child
11. Causes of InfertilityCauses of Infertility
Anovulation (10-20%)(10-20%)
Anatomic defects of the female genital tract (30%)(30%)
Abnormal spermatogenesis (40%)(40%)
Unexplained (10%-20%)(10%-20%)
Causes:Causes:
Male causes
Female causes
Combined causes
12. Male FactorMale Factor
40% of the cause for infertility
Sperm is constantly produced by the germinal epithelium ofSperm is constantly produced by the germinal epithelium of
the testiclethe testicle
Sperm generation time 73 days
Sperm production is thermoregulated
1° F less than body temperature
Both men and women can produce anti-sperm antibodiesanti-sperm antibodies
which interfere with the penetration of the cervical mucus
15. A. Gonadotropin Deficiency (Kallmann Syndrome)
failure of GnRH neurons to migrateGnRH neurons to migrate to the proper
location in the hypothalamus.
Kallmann syndromeKallmann syndrome is associated with midline defects
such as anosmia, cleft lip and cleft palate, deafness,
cryptorchidism, and color blindness.
Men can be fertile when given FSH and LH to stimulategiven FSH and LH to stimulate
sperm productionsperm production. Virilization can be obtained with
testosterone or human chorionic gonadotropin (hCG)
16. –C. Isolated FSH Deficiency
there is insufficient FSH production by the pituitary. Patients are
normally virilized, as LH is present. FSH levels are low. Sperm
counts range from azoospermia to severely low numbers
(oligospermia).
–D. Congenital Hypogonadotropic Syndromes
Prader-Willi syndrome Bardet-Biedi syndrome.
17. –A. Pituitary Insufficiency
Pituitary insufficiency may result from tumors, infarcts, surgery,from tumors, infarcts, surgery,
radiation, sickle cellradiation, sickle cell anemia.
–B. Hyperprolactinemia
–most common cause is prolactin-secreting pituitary adenoma.
–Elevated prolactin results in decreased FSH, LH levels andElevated prolactin results in decreased FSH, LH levels and
causes infertilitycauses infertility.
–Associated symptoms include loss of libido, impotence,include loss of libido, impotence,
galactorrhea, and gynecomastia.galactorrhea, and gynecomastia.
–C. Exogenous or Endogenous Hormones
1. Estrogens, GH, androgens, glucocorticoids, Hyper- andEstrogens, GH, androgens, glucocorticoids, Hyper- and
hypothyroidismhypothyroidism
18.
19. Chromosomal Causes
• Klinefelter syndrome (47,XXY)Klinefelter syndrome (47,XXY)
– most common genetic reason for azoospermia. classic triad:
small firm testes; gynecomastia; and azoospermiasmall firm testes; gynecomastia; and azoospermia.
– XX Male SyndromeXX Male Syndrome
– presents as gynecomastia at puberty or as azoospermia ingynecomastia at puberty or as azoospermia in
adultsadults. Average height is below normal, and hypospadiashypospadias is
common. Male external and internal genitalia are otherwise normal.
– XYY SyndromeXYY Syndrome
– Typically, men with 47,XYY are tall. Semen analyses show either
oligospermia or azoospermia.
20. –Causes of Male infertility - Gonadotoxins
RadiationRadiation :
– Sertoli and germ cells are extremely radiosensitive.
Drugs:Drugs:
21. –Use of alcohol, cigarettes, caffeine, and marijuana may lead to
testicular failure.
–Chemotherapy: toxic to actively dividing cells The most toxic
drugs are the alkylating agents such as cyclophosphamide.
– Systemic Disease - Causes of Male infertility
A.Renal Failure
B. Liver Cirrhosis
C. Sickle Cell Disease
22. – Causes of Male infertility - Testis Injury
OrchitisOrchitis
– Inflammation of testis tissue is most commonly due to bacterial
infection, termed epididymo-orchitis.
Testicular TorsionTesticular Torsion :
Ischemic injury to the testis secondary to twisting of the testis on the
spermatic cord. Torsion may result in inoculation of the immune
system with testis antigens that may predispose to later
immunological infertility.
TraumaTrauma
Can invoke an abnormal immune response in addition to atrophy
resulting from injury. Both may contribute to infertility.
23. –Causes of Male infertility - Cryptorchidism
–Males with either unilaterally or bilaterally undescended testes are at
risk for infertility later in life. Prophylactic orchidopexy is generally
performed by 2 years of age
–Varicocele
–A varicocele is defined as dilated and tortuous veins within the
pampiniform plexus of scrotal veins.
–Increased intratesticular temperature, reflux of toxic metabolites
–
–Idiopathic
–at least 25%-50% of male infertility has no identifiable cause
24.
25. –Posttesticular Causes of Male infertility
–The posttesticular portion of the reproductive tract includes the
epididymis, vas deferens, seminal vesicles, and associatedepididymis, vas deferens, seminal vesicles, and associated
ejaculatory apparatusejaculatory apparatus
–1. Cystic fibrosis -
–98% of men with CF having missing
parts of the epididymis. In addition, the
vas deferens, seminal vesicles, and
ejaculatory ducts are usually atrophic, or
completely absent
–2.Bacterial infections - Bacterial infections (E coli in men age
> 35) or Chlamydia trachomatis in young men) may involve the
epididymis, with scarring and obstruction.
26. –Retrograde ejaculation:
–This is caused by an open bladder neck during
ejaculation.
–Retrograde ejaculation may be due to causes such as
diabetes, bladder neck surgery, TURP, colon or rectal surgery,diabetes, bladder neck surgery, TURP, colon or rectal surgery,
multiple sclerosis, or spinal cord injury.multiple sclerosis, or spinal cord injury.
–Diagnosis is made by observing 10-15 sperm per high-
power field (HPF) in the postejaculatory urine.
27. –Disorders of Sperm Function or Motility
A. Immotile Cilia Syndromes
–B. Immunologic Infertility
Autoimmune infertility has been implicated as a cause of infertility in 10% of10% of
infertile couples..infertile couples..
– Autoimmune infertility may result from an abnormal exposure to sperm antigens
after, for example, Vasectomy, testis torsion, or biopsy, which then a pathologicVasectomy, testis torsion, or biopsy, which then a pathologic
immune response.immune response.
–Antibodies disturb sperm transport or normal sperm-egg interaction.
–Antibodies may cause agglutination of sperm, which inhibits passage,
– or may block normal sperm binding to the oocyte
29. –Disorders of Coitus - Causes of Male infertility
A. Impotence
B. Sexual issues.
– Often treatable, problems with sexual intercourse Difficulties with
erection of the penis (erectile dysfunction), premature ejaculation,
painful intercourse (dyspareunia), or psychological or relationship
problems can contribute to infertility. Use of lubricants such as oils or
petroleum jelly can be toxic to sperm and impair fertility.
–C. Hypospadias
May not place the semen at the cervical os.
–D. Timing and Frequency
Simple problems of coital timing and frequency can be corrected by a review of
the couple’s sexual habits. An appropriate frequency of intercourse is every 2
days, performed within the periovulatory period.
30. ComponentsComponents ofof thethe infertilityinfertility historyhistory.
Fertility historyFertility history
Previous pregnancies (present and with other partners)
Duration of infertility
Previous infertility treatments
Female evaluation
Sexual historySexual history
Erections
Timing and frequency
Lubricants
Medical historyMedical history
Fevers
Systemic illness—diabetes, cancer, infection
Genetic diseases—cystic fibrosis, Klinefelter syndrome
31. Surgical historySurgical history
Orchidopexy, cryptorchidism
Herniorraphy
Trauma, torsion
Pelvic, bladder, or retroperitoneal surgery
Transurethral resection for prostatism
Pubertal onset
Medication historyMedication history
Nitrofurantoin
Cimetidine
Sulfasalazine
Spironolactone
Alpha blockers
32. Family historyFamily history
Cryptorchidism
Midline defects
(Kartagener syndrome)
Hypospadias
Social historySocial history
Ethanol
Smoking/tobacco
Cocaine
Anabolic steroids
Occupational historyOccupational history
Exposure to ionizing radiation
Chronic heat exposure
Pesticides
Heavy metals (lead)
33. Laboratory Diagnosis of Male InfertilityLaboratory Diagnosis of Male Infertility
UrinalysisUrinalysis
It may indicate the presence of infection, hematuria, glucosuria, or renal
disease, and suggest anatomic or medical problems within the urinary tract
Semen AnalysisSemen Analysis
•A normal semen analysis excludes male factor 90% of the time
34. Semen Analysis (SA)Semen Analysis (SA)
Obtained by masturbation
Provides immediate information
Quantity
Quality
Density of the sperm
Morphology
Motility
Abstain from coitus 2 to 3 days
Collect all the ejaculate
Analyze within 1 hour
35. Abnormal Semen AnalysisAbnormal Semen Analysis
AzospermiaAzospermia
Klinefelter’s (1 in 500)
Hypogonadotropic-
hypogonadism
Ductal obstruction
(absence of the Vas
deferens)
OligospermiaOligospermia
Anatomic defects
Endocrinopathies
Genetic factors
Exogenous (e.g. heat)
36. Cont. causes for abnormal SACont. causes for abnormal SA
Abnormal MorphologyAbnormal Morphology
Varicocele
Stress
Infection (mumps)
Abnormal MotilityAbnormal Motility
Immunologic factors
Infection
Defect in sperm structure
Poor liquefaction
Varicocele
Abnormal VolumeAbnormal Volume
No ejaculate
Ductal obstruction
Retrograde ejaculation
Ejaculatory failure
Hypogonadism
Low Volume
Obstruction of ducts
Absence of vas deferens
Absence of seminal vesicle
Partial retrograde ejaculation
Infection
37. Hormone Assessment :Hormone Assessment :
A routine part of the initial evaluation is testing of specific serum hormone
levels, which usually includes FSH, LH, testosterone, and prolactin.
40. MenstruationMenstruation
Ovulation occurs 13-14 times per year13-14 times per year
Menstrual cycles on average are 28 daysare 28 days with ovulation around day 14
Luteal phase
dominated by the secretion of progesteronedominated by the secretion of progesterone
released by the corpus luteumreleased by the corpus luteum
Progesterone causes
Thickening of the endocervical mucusThickening of the endocervical mucus
Increases the basal body temperature (0.6° F)Increases the basal body temperature (0.6° F)
Involution of the corpus luteum causes a fall in progesterone and the
onset of menses
41. OvulationOvulation
A history of regular menstruation suggests regular
ovulation
The majority of ovulatory women experience
fullness of the breasts
decreased vaginal secretions
abdominal bloating
mild peripheral edema
slight weight gain
depression
42. Diagnostic studies to confirm OvulationDiagnostic studies to confirm Ovulation
Basal body temperatureBasal body temperature
Inexpensive
Accurate
Endometrial biopsyEndometrial biopsy
Expensive
Static information
Serum progesteroneSerum progesterone
After ovulation rises
Can be measured
Urinary ovulation-Urinary ovulation-
detection kitsdetection kits
Measures changes in urinary
LH
Predicts ovulation but does
not confirm it
43. Basal Body TemperatureBasal Body Temperature
Excellent screening tool for ovulationExcellent screening tool for ovulation
Biphasic shift occurs in 90% of ovulating women
TemperatureTemperature
drops at the time of menses
rises two days after the lutenizing hormone (LH) surge
Ovum released one day prior to the first rise
Temperature elevation of more than 16 days suggests
pregnancy
50. Sperm transport, Fertilization, &Sperm transport, Fertilization, &
ImplantationImplantation
The female genital tract is not just a passage:The female genital tract is not just a passage:
facilitates sperm transport
cervical mucus traps the coagulated ejaculate
the fallopian tube picks up the egg
Fertilization must occur in the proximal portion ofFertilization must occur in the proximal portion of
the tubethe tube
the fertilized oocyte cleaves and forms a zygote
enters the endometrial cavity at 3 to 5 days
Implants into the secretory endometrium for growthImplants into the secretory endometrium for growth
and developmentand development
52. AnovulationAnovulation
Symptoms EvaluationSymptoms Evaluation
Irregular menstrual cycles
Amenorrhea
Hirsuitism
Acne
Galactorrhea
Increased vaginal secretions
Follicle stimulating hormone
Lutenizing hormone
Thyroid stimulating hormone
Prolactin
Androstenedione
Total testosterone
*Order the appropriate tests based on the clinical indications
53. Investigations:Investigations:
ovulatoryovulatory
day 3: FSH, LH, TSH, PRL ± DHEA, free testosterone (if hirsute)
day 21-23: serum progesterone to confirm ovulation
initiate basal body temperature monitoring (biphasic pattern)
post-coital test (Sims-Huhner's Test) cervical mucus after 2-6hrs of intercourse to look
for present motile sperm
• tubal factorstubal factors
HSG (can be therapeutic – opens fallopian tube)
laparoscopy with dye insufflation
• peritoneal/uterine factorsperitoneal/uterine factors
HSG, hysteroscopy
• otherother
karyotype
–Ultrasound scans can detect the development
of the follicle and its collapse after ovulation. Vaginal
ultrasound scan gives a much clearer picture than the
abdominal scan. The follicle is usually ready for
ovulation when it measures 1.8 - 2.5 cm in diameter.
54. HysterosalpingogramHysterosalpingogram
An X-ray that evaluates
the internal female genital
tract
architecture and integrity
of the system
Performed between the
7th
and 11th
day of the cycle
Diagnostic accuracy of
70%
57. Inadequate SpermatogenesisInadequate Spermatogenesis
Conservative management:Conservative management:
Intercourse every 1-2 days during periovulatory period
(12-16)
Women advice to lie on her bake at least 15 min after
coitus prevent rapid loss of semen from vagina
Use non-toxic lubricant
Smoking should be reduced or stopped.
Eliminate alterations of thermoregulation
58. MALE INFERTILITYMALE INFERTILITY
Clomiphene citrate is occasionally used for induction of
spermatogenesis (20% success)
Administration of bromocriptine for hyperprolactinemic
patient.
Injection of human menaposa gonadotropins (hMG) for
oligospermia and low motility of sperm.
In vitro fertilization may facilitate fertilization
Artificial insemination with donor sperm is often successful
Intracytoplasmic sperm injection
59. AnovulationAnovulation
Restore ovulation
Administer ovulation inducing agents
Weight modulation — Ovulation dysfunction and subfertility may
occur in women who are far above or below ideal body weight
Clomiphene citrate
Anti-estrogen
Combines and blocks estrogen receptors at the
hypothalamus and pituitary causing a negative feedback
Used in the treatment of polycystic ovarian syndrome.
Contraindication hepatic disease, ovarian cysts, hormone
dependent tumours, abnormal uterine bleeding of
undetermined cause
Increases FSH production
stimulates the ovary to make follicles
60. Human menopause gonadotropin (hMG) (FSH &LH)
used for whom don't ovulate due to problems with the pituitary
gland, acts directly on the ovaries to stimulate ovulation.
Follicle-stimulating hormone (FSH) causes the ovaries to
begin the process of ovulation.
Gonadotropin-releasing hormone (Gn-RH) analog used
for whom don't ovulate regularly or ovulate before the egg is ready
Metformin use for PCOS, lower the levels of testosterone.
Bromocriptine for ovulation problems due to high levels of
prolactin.
61. Anatomic AbnormalitiesAnatomic Abnormalities
Surgical treatments
Lysis of adhesions
Septoplasty
Tuboplasty
Myomectomy
Surgery may be performed
laparoscopically
hysteroscopically
If the fallopian tubes are beyond repair one must
consider in vitro fertilization
62. Management of unexplained infertilityManagement of unexplained infertility
The most efficient management is clomiphene citrate and
performance of intrauterine insemination (IUI).
If this has not resulted in pregnancy, it appears most useful to
subsequently perform in vitro fertilization (IVF).
The administration of clomiphene citrate is intended to achieve
ovulation induction or ovarian hyperstimulation.
Human chorionic gonadotropin (hCG) is given to trigger
ovulation, and the intrauterine insemination is performed within 2
days of hCG administration.
63. Ovarian hyper stimulation syndrome
(OHSS):
Is a complication from some form of fertility medication
Causative medication: HCG used for inducing final oocyte
maturation
65. Prevention of OHSS:Prevention of OHSS:
monitoring of FSH therapy to use this medication judiciously, and by
withholding hCG medication.
Regarding dopamine agonists as prophylaxis.
TREATMENT:
Mild:Mild: conservative management with monitoring of abdominal girth,
weight, and discomfort on an outpatient basis until either conception or
menstruation occurs
ModerateModerate: bed rest, fluids, and close monitoring of labs such as
electrolytes and blood counts. Ultrasound may be used to monitor the size
of ovarian follicles
Aspiration of accumulated fluidAspiration of accumulated fluid
opioids for the painopioids for the pain
66. Assisted Reproductive TechnologiesAssisted Reproductive Technologies
(ART)(ART)
Theses technologies help provide infertile couples with tools to
bypass the normal mechanisms of gamete transportation.
ART is a term that describes several different methods used
to help infertile couples. It involves removing eggs, mixing them
with sperm in the laboratory and putting the embryos back into a
woman's body.
67. Types of ARTTypes of ART
In vitro fertilization (IVF) often used when a woman's fallopian tubes are
blocked or when a man produces too few sperm.
Gamete intrafallopian transfer (GIFT) involves transferring eggs and sperm
into the woman's fallopian tube.
Intracytoplasmic sperm injection (ICSI) is often used for couples in which
there are serious problems with the sperm, older couples, or for those with failed IVF
attempts. In ICSI, a single sperm is injected into a mature egg. Then the embryo is
transferred to the uterus or fallopian tube.
Artificial insemination:
is the deliberate introduction of semen into a female's vagina
It is the medical alternative to sexual intercourse, or natural insemination.
Techniques:
Intracervical insemination
Intrauterine insemination
Intrauterine tuboperitoneal insemination
Intratubal insemination
68. Emotional ImpactEmotional Impact
Infertility places a great emotional burden on the
infertile couple.
The quest for having a child becomes the driving force of
the couples relationship.
It is important to address the emotional needs of these
patients.
69. ConclusionConclusion
Infertility should be evaluated after one year of unprotected
intercourse.
History and Physical examination usually will help to identify
the etiology.
If patients fail the initial therapies then the proper referral
should be made to a reproductive specialist.
Estrogens - An excess of sex steroids, either estrogens or androgens, can cause male infertility due to an imbalance in the testosterone-estrogen ratio. E.g Hepatic cirrhosis, adrenocortical tumour.
2.Androgens - An excess of androgens can suppress pituitary gonadotropin secretion and lead to secondary testis failure. The use of exogenous androgenic steroids (anabolic steroids) result in temporary sterility due to this effect.
3. Glucocorticoids - Exposure to excess glucocorticoids either endogenously or exogenously can result in decreased spermatogenesis. Elevated plasma cortisone
levels depress LH secretion and induce secondary testis failure.
4. Hyper- and hypothyroidism - Abnormally high or low levels of serum thyroid hormone affect spermatogenesis Thyroid abnormalities are a rare cause (0.5%) of male infertility.
5. Growth hormone - Some infertile men have deficient responses to growth hormone challenge tests and may respond to growth hormone treatment with improvements in semen quality